Lennham Patents – Insights & Stats (Updated 2023)

Lennham has a total of 47 patents globally, out of which 10 have been granted. Of these 47 patents, more than 80% patents are active. United States of America is where Lennham has filed the maximum number of patents, followed by Europe and Taiwan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Lennham.

Lennham was founded in the year 2019. The Company helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.

Do read about some of the most popular patents of Lennham which have been covered by us in this article and also you can find Lennham patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Lennham patent portfolio.

How many patents does the founder and the CEO of Lennham have?

The founder and CEO Bradford Sippy has 5 patents.

How many patents does Lennham have?

Lennham has a total of 47 patents globally. These patents belong to 10 unique patent families. Out of 47 patents, 38 patents are active.

How Many Patents did Lennham File Every Year?

Lennham Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantLennham Applications FiledLennham Patents Granted

How many Lennham patents are Alive/Dead?

Lennham Patent Portfolio

 How Many Patents did Lennham File in Different Countries?

Lennham Worldwide Patent Filing

Countries in which Lennham Filed Patents

United States Of America17
New Zealand1
Korea (South)1
Hong Kong (S.A.R.)1
South Africa1

Where are Research Centres of Lennham Patents Located?

The Research Centre for all the Lennham patents is the United States of America.

10 Best Lennham Patents

US11000534B1 is the most popular patent in the Lennham portfolio. It has received 26 citations so far from companies like Small Pharma Ltd, Terran Biosciences and Enveric Biosciences Canada.

Below is the list of 10 most cited patents of Lennham:

Publication NumberCitation Count

What Percentage of Lennham US Patent Applications were Granted?

Lennham (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 80.0%.

Below are the key stats of Lennham patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Lennham?

Law FirmTotal ApplicationsSuccess Rate
Lennham Pharmaceuticals871.43%
Foley Hoag Llp General4100.00%

List of Lennham Patents

Lennham PatentsTitle
US11666073B2Deuterated Caffeine And Uses Thereof
US11633371B2Deuterated Forms Of Acetaminophen And Uses Thereof
US11547127B2Deuterated Caffeine And Uses Thereof
US11471469B2Deuterated Forms Of Testosterone And Methods Of Use
US11344564B1Method Of Treatment Based On Reduced Monoamine Oxidase A Activity
US11324762B2Deuterated Derivatives Of Psilocybin And Uses Thereof
US11202785B1Deuterated Forms Of Testosterone And Methods Of Use
US11000534B1Deuterated Derivatives Of Psilocybin And Uses Thereof
US10765130B1Deuterated Caffeine And Uses Thereof
US10582716B1Deuterated Caffeine And Uses Thereof
US20230124138A1Deuterated Forms Of Testosterone And Methods Of Use
US20230062523A1Method Of Treatment Based On Reduced Monoamine Oxidase A Activity
US20220313630A1Deuterated Forms Of Acetaminophen And Uses Thereof
US20220288083A1D9 Caffeine Compositions And Uses Thereof
US20220110955A1Deuterated Derivatives Of Psilocybin And Uses Thereof
EP4255439A1Deuterated Forms Of Testosterone And Methods Of Use
EP3979999A4Deuterated Forms Of Acetaminophen And Uses Thereof
EP3982759A4Deuterated Caffeine And Uses Thereof
CN114007622ADeuterated Caffeine And Uses Thereof
WO2023043899A1Deuterated Derivatives Of Salvinorin A And Uses Thereof
WO2023023155A1Method Of Treatment Based On Reduced Monoamine Oxidase A Activity
WO2022225884A1Deuterated Derivatives Of Psychedelic Compounds And Uses Thereof
CA3138347A1Deuterated Caffeine And Uses Thereof
HK40067705ADeuterated Caffeine And Uses Thereof
MX2021015509ADeuterated Caffeine And Uses Thereof.
AU2020292375A1Deuterated Caffeine And Uses Thereof
IL288944ADeuterated Caffeine And Uses Thereof
JP2022536928A5Deuterated Caffeine And Uses Thereof
RU2021139137ADeuterated Caffeine And Its Applications
TW202237139ADeuterated Forms Of Testosterone And Methods Of Use
TW202228716ADeuterated Derivatives Of Psilocybin And Uses Thereof
TW202227085ADeuterated Paraxanthine And Uses Thereof
IN202217001705ADeuterated Caffeine And Uses Thereof
KR1020220020898ADeuterated Caffeine And Uses Thereof
BR112021023614A2Deuterated Caffeine And Its Uses
SG11202112395SADeuterated Caffeine And Uses Thereof
ZA202108446ADeuterated Caffeine And Uses Thereof
NZ781723ADeuterated Caffeine And Uses Thereof
US20210378266A9Deuterated Caffeine And Uses Thereof
US20200390128A1Deuterated Caffeine And Uses Thereof
WO2022192271A1D9 Caffeine Compositions And Uses Thereof
WO2022159813A1Products Comprising Deuterium Enriched Water
WO2022120054A1Deuterated Forms Of Testosterone And Methods Of Use
WO2022056190A3Deuterated Paraxanthine And Uses Thereof
WO2022076642A1Deuterated Derivatives Of Psilocybin And Uses Thereof
WO2020252302A1Deuterated Caffeine And Uses Thereof
WO2020247458A1Deuterated Forms Of Acetaminophen And Uses Thereof

What are Lennham key innovation segments?

What Technologies are Covered by Lennham?

The chart below distributes patents filed by Lennham in different countries on the basis of the technology protected in patents. It also represents the markets where Lennham thinks it’s important to protect particular technology inventions.

R&D Focus: How has Lennham search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Lennham?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.